cdmo.directory
← Compare landing

Celularity vs Hillgene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/celularity/hillgene

CategoryCelularityHillgene
Listed sitecdmocdmo
SummaryCelularity is a clinical and commercial-stage biotechnology company specializing in off-the-shelf placental-derived allogeneic cell therapies and advanced biomaterial products.Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Cell Therapy
  • mRNA
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
  • Immunology
Locations
  • Headquarters & Manufacturing, United States
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
CertificationsData not yet provided.
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.